Evidence map›Paper›PMID 31183564›Full record

ArticleMikrochimica acta2019

3D-printed CuO nanoparticle-functionalized flow reactor enables online fluorometric monitoring of glucose.

Cheng-Kuan Su, Hsin-Heng Tseng

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Cheng-Kuan SuDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, No.2, Beining Road, Keelung, 20224, Taiwan. chengkuan@mail.ntou.edu.tw.ORCID 0000-0003-1306-9202
Hsin-Heng TsengDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, No.2, Beining Road, Keelung, 20224, Taiwan.

Funding

Ministry of Science and Technology of the Republic of China MOST 106-2113-M-019-002-MY2
6 · The paper itself

Abstract

An online flow reactor was fabricated by using a fused deposition modeling three-dimensional printing (3DP) technology along with thermoplastic poly(lactic acid) filaments incorporating copper oxide nanoparticles (CuO NPs). In the presence of glucose, the flow reactor displays multi-catalytic activities because accelerates the oxidation of 2',7'-dichlorodihydrofluorescein to form fluorescein which displays green fluorescence under 480 nm excitation (emission wavelength: 530 nm). The CuO NPs exert two functions to mediate electron transfer at a basic reaction condition, viz. direct oxidation of glucose to generate reactive oxygen species (ROS), and prompting the ROS to oxidize 2',7'-dichlorofluorescin diacetate. The flow reactor coupled to a microdialysis sampler and a fluorometer was applied for online fluorometric monitoring of brain extracellular glucose levels in living rats based on scanning of time-resolved fluorescence intensities. After optimization of (a) the manufacture of the flow reactor, (b) the reaction conditions (pH 10; 50 °C), and (c) the online analytical system, the detection limit of the method (when using 10-μL samples of microdialysate) is as low as 6.1 μM (linear range: 0.05-5 mM) with a sampling frequency of 7.5 h

Indexed as

Printing, Three-DimensionalAnimalsBiosensing TechniquesBrainCopperFluoresceinsFluorescent DyesGlucoseLimit of DetectionMaleMetal NanoparticlesMicrodialysisMonitoring, PhysiologicOxidation-ReductionPolyestersRats2',7'-dichlorodihydrofluoresceinCoppercuprous oxideFluoresceinsFluorescent DyesGlucosePolyesterspoly(lactide)Reactive Oxygen SpeciesAdditive manufacturingBrain extracellular fluidCuO nanoparticlesDCFH-DAEnzyme mimicIncorporationIn vivo monitoringReactive oxygen species

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.